Takeda Pharmaceutical Company Limited
4502
Rangering i aksjer
#378
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
Aksjekurs
$40.26
Markedsverdi
$64.06B
Endring (1 dag)
0.71%
Endring (1 år)
42.44%
Land
JP
Handel Takeda Pharmaceutical Company Limited (4502)
Kategori
Healthcare
Historikk for aksjesplitt for Takeda Pharmaceutical Company Limited (4502)
Aksjen Takeda Pharmaceutical Company Limited (symbol: 4502) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én 4502-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 4502-aksjer.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én 4502-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 4502-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
|
| 0 | - |
CN
|
